Juvenile chronic myelocytic leukemia (JCML) is a rare hematopoietic neoplasia of early childhood with distinct hematologic and biochemical features. We studied the biologic properties and the globin synthetic profiles of JCML erythroid cells both in vivo and in vitro from a total of 24 patients. In these cases we observed the exuberant colony-forming unit-macrophage (CFU-M) colony growth, as reported previously. Furthermore, in contrast t o previous reports, we found significant erythroid colony growth in most of our cases (average: 1,182 burst-forming unit-erythroid [BFUe] per I O 5 plated cells, range: 40 t o 6,927). This growth was by and large erythropoietin-dependent and was not greatly influenced by other added cytokines. By several criteria all erythroid colony growth detected in vitro was derived from UVENILE CHRONIC myelocytic leukemia (JCML) is J a distinct but rare hematologic entity of early childhood. It is a clonal leukemic disorder involving the pluripotent stem cell',2 and it is expressed with a hematologic phenotype of a myelomonocytic le~kemia.~.' Characteristic in JCML is the consistent increase in fetal hemoglobin (Hb F) in the peripheral blood (PB) of patients8-I4 and the spontaneous and exuberant growth of monocyte/macrophages in ~itro.~,'' Cytogenetically, in contrast to classic PhTML, it lacks the Philadelphia chromosome and in the majority of cases no characteristic chromosomal abnormalities are
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Although an increase in Hb F is a regular feature of the disease, studies of globin patterns in a large series of patients both in vivo and in vitro are lacking, presumably because of the reported difficulties for achieving successful in vitro growth of JCML erythroid progenitor^.^'
In the present study we have characterized the clonogenic potential and some of the growth requirements of JCML erythroid progenitors and analyzed their globin expression patterns.
The exuberant and spontaneous growth of monocyte/ macrophage JCML progenitors characteristic of JCML was present in most of our cases. In addition and in contrast to many previous reports, we show that clonogenic cells of the erythroid series (burst-forming unit-erythroid [BFUe] ) are present in high numbers, often with high proliferative potential in both the PB and the bone marrow (BM) of these patients. Erythroid growth was largely erythropoietin (Epo)-dependent; lesser influences from the addition of other hematopoietic growth factors were observed. The globin program expressed by JCML erythroid progenitors in vitro covers the spectrum of patterns seen from the early fetal liver stage to the neonatal stage of erythropoiesis and includes the production of embryonic globins, which has not been previously reported for primary leukemic cells. By several criteria all the erythroid colony growth has been attributed to leukemic, erythroid progenitors and not to normal progenitors.
The high fetal globin production in JCML in vivo is attributed to the neoplastic transformation of a "postswitched" adult stem cell, rather than of a "preswitched" (fetal) or "partially switched" (neonatal) stem cell. In contrast to other common acute leukemias or erythroleukemias, JCML erythroid cells are capable of reaching full maturity in vivo to the level of the red blood cell (RBC), thus making Hb F readily detectable in PB.
MATERIALS AND METHODS

Patients
Fourteen patients included in this study have been evaluated at Fred Hutchinson Cancer Research Center (FHCRC) as candidates for BM transplantation." Their diagnosis was either firmly established or presumed 4 to 13 months before their arrival at FHCRC. The remainder of the patient samples was sent to us from St Jude Children's Hospital, Memphis, TN (Dr L. Dow) and one sample was sent to us by Dr J. Prchal (University of Alabama, Birmingham). Patients or their parentsllegal guardians were informed that blood andlor bone marrow samples were obtained for research purposes, and that their privacy will be protected. Approval was obtained by Institutional Human Experimentation Committees for these studies.
Cell Cultures
Both PB and BM samples were used for cell cultures. These samples were either cultured on the day they were drawn or shipped to us and used the following day. For clonogenic progeni- Grand Island, NY). In addition to these culture components, Epo was used at 0.2 to 4 UimL, interleukin-3 (IL-3) at 5 to 1,500 UlmL, granulocyte-macrophage colony-stimulating factor (GM-CSF) at 10 to 500 U/mL (all from Genetics Institute, Cambridge, MA) and in a few experiments, 10 to 40 UimL 1L-1 (Genzyme, Boston, MA), 50 ng/mL Activin (Genentech, South San Francisco, CA), or 1,000 U/mL of IL-9 were used (Genetics Institute). The number of cells plated varied from 500 to 300,000 per mL.
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Hb Analysis
PB smears were subjected to immunofluorescent labeling with previously describedu-= anti-globin chain antibodies (anti+, anti-y, anti-e, and anti-l). In addition, cytocentrifuge preparations from pooled or single bursts were labeled with the same antibodies.
For this purpose, fully hemoglobinized bursts were individually plucked from culture plates, pooled, and labeled with 750 pCi/mL 'H-leucine (Amersham, Arlington Heights, IL) in the presence of leucine-free media for 12 to 17 hours at 37°C in a 5% CO, incubator. Following labeling, they were washed and either used for isoelectric focusing or frozen for later use. Following isoelectric focusing the gels were fixed with En3Hance (DuPont, Boston, MA) and subjected to autoradiography as previously described.z6
Total cellular RNA was prepared by cell lysis in 4 mol/L guanidine hydrochloride followed by cesium chloride gradient centrifugation. The RNA pellet was dissolved in 2 mL of NETS buffer (100 mmol/L NaCI, 10 mmol/L Tris hydrochloride [pH 7.51, 1.0 mmol/L EDTA, and 1.0% sodium dodecyl sulfate) and following phenol extraction was precipitated twice in ethanol and stored at -70°C. After centrifugation, RNA was dissolved and used for S1 nuclease analysis.
Uniformly labeled M13 MP7 probes specific for p, y, e, and 5 globin RNA were used and hybridization conditions under probe excess were as described in detail previ~usly.~~
RESULTS
The Hematologic Profile of Patients
We studied a total of 24 patients, from 1 to 5 years of age, either close to the time of diagnosis or several months after the original diagnosis. All patients were slightly to moderately anemic with a different proportion of total white cells (1,100 to 106,000/mm3) or blasts (4% to 60%) in their blood and most of the patients were thrombocytopenic. Not all tests were performed in all patients. Determination of Hb F in PB was performed in patients not recently (within the last 3 months) transfused (Table 1 ). Levels of Hb F i n those patients ranged from 23% to 51% and their F cells (RBCs containing Hb F) were from 66% to 100% (Fig 1) . In some patients repeated determinations were available and showed mild fluctuations over time.
Globin biosynthesis in PB was performed in some of the untransfused patients and showed a fetal (y) globin level from 53% to 94% with over two-thirds being of the Gy type.
Immunofluorescent studies.
Globin chain isoelectric focusing.
Preparation of RNA and SI nuclease assay. In 11 patients we also had the opportunity to test titers of i and I antigens (by agglutination) and the data are presented in Table 2 . As can be seen from these data, the ratio of i to 1 ranged from 1:4 to 32:l. Thus, i antigen was extremely high and exceeded that of I antigen in several patients, as the ratio was reversed from that normally observed in adults (i:I = 1:64). Almost half of the patients had been treated with prior chemotherapy and the majority had been transfused at some time before our study. With two exceptions (patients 12 and 20), all patients had normal cytogenetics. No patients with monosomy 7 were included.
Clonogenic Progenitors in JCML and the Effect of Growth Factors
PB samples were cultured from 16 JCML patients and BM samples from 10 such patients. The number of BFUe per lo5 plated cells ranged from 40 to 6,927 ( Table 3) . The colony growth in four patients was in the upper limit observed in normal individuals (from 40 to 100) but in the rest of the patients it ranged from twofold to 70-fold higher than normal. Patients who had high erythroid colony growth also had exuberant granulocyticlmonocytic colony growth, but there were exceptions ( Table 3) . When a range of plated cells (500 cells to 300,000 cells/plate) was used, it was observed that the erythroid colony growth was usually suppressed in high inocula (eg, 3 x lo'), presumably because of overwhelming macrophage growth. Erythroid colonies grown from these patients usually appeared early in culture, ie, during the first week, as unicentric, pale, translucent colonies with very sharp borders. The degree of hemoglobinization later in culture varied from patient to patient, but there was also variation within a given culture from the same patient.
Endogenous erythroid colony growth, eg, growth in the absence of added Epo, was observed in a minimum of four of nine patients tested ( Table 4) . Such endogenous erythroid colonies represented (with one exception) a small fraction of the total colonies grown in the presence of Epo. vitro could improve if colonies were grown away from the influence of background cells.
Patterns of Globin Synthesis In fitro
When globin biosynthesis of BFUe-derived erythroblasts was assessed, the level of Hb F ranged from 62% to 98% and the proportion of ' -y was from 33% to 77% (Table 5 ) .
Although there was variation from patient to patient, values were consistent within the same individual when several pools of bursts were tested. In one experiment, 22 single bursts were plucked at random and labeled. The globin synthesis of these individual bursts ranged from 79% to 96% Hb F, whereas there was 90% Hb F in a pool of 88 bursts. We also examined whether the level of Hb F was influenced by fetal sheep serum (FSS), charcoal-treated FCS (FCS-T), or human adult sera, as is the case in BFUe cultures from normal As seen in Table 5 , these sera were incapable of modulating Hb F levels in the JCML cultures, in contrast to the data of normal cultures in which FSS or FCS-T virtually abrogate the in vitro activation of Hb F." The addition of cytokines (500 U of IL-3, alone or in combination with 300 U IL-6) did not change the pattern of globin biosynthesis (Fig 2) . Pooled bursts from seven patients were also tested by immunofluorescence using antibodies directed against embryonic (E and (), fetal (y), and adult (Sp) globins (Figs 3   and 4) . In all cases studied we were able to detect the presence of a few cells that contained embryonic globins (among pooled burst populations). These cells were not derived by a separate set of bursts because labeling of individual bursts (example shown in Fig 4) showed scattered €-positive or (-positive cells within these bursts. The proportion of €-positive cells ranged from less than 1% to 13% while the proportion of (-positive cells ranged from about 2% to 30% (Table 6 ). Presence of embryonic globins was confirmed at the RNA level using S1 nuclease mapping (Fig 5) . In one case, fresh blasts were used for S1 nuclease assay and E messenger RNA (mRNA) was detected (Fig 5) .
DISCUSSION
One of the hallmarks of JCML is the abundant endogenous clonal growth of predominantly myelo-monocytic progenitors in vitro along with the prevalence of immature monocytoid cells in This "endogenous" or "spontaneous" growth of monocytic colonies in vitro appears to be dependent on the presence of adherent cells or their products and, therefore, is considered to be nonauton-O~O U S .~' Whether the specific overproduction of IL-1 or GM-CSF are the factors responsible, as previously suggested, is ~n c l e a r ?~,~~ Enhanced sensitivity to GM-CSF and/or to an as yet unidentified growth factor with quantitative or qualitative aberrations in the expression of the growth factor receptor could also be the underlying mechanism."' The heightened sensitivity to Epo, which we observed here, may also be considered as part of the altered pattern of responsiveness of JCML progenitors. Further, endogenous colony-forming unit-macrophage (CFU-M) growth, as previously described, was present in the cases studied here. However, this type of in vitro growth has bcen observed in other myelomonocytic leukemias of early childhood. including monosomy 7 or myclodysplasias, that may or may not be variants of JCML."
In prcvious JCML studics in which the cxubcrant monoqtidmacrophagc colonics were noted, erythroid growth has bccn dcscribcd infrequently and only in isolated cases."" Furthcrmorc, failurc to grow erythroid colonics has been emphasized as one of thc distinguishing fcaturcs of the discasc, including inhibition of normal crythroid progenitors by JCML cells." In contrast to thcsc data, wc have uncovered significant (several-fold highcr than normal) erythroid colony growth in thc majority of our cascs. Thc rcasons for ditfercnces betwccn the prcviously rcportcd data and ours arc not readily apparent. Wc suspect that ditfcrcnccs in culture componcnts and innocula do play a rolc. High innocula or ovcrwhclming growth of JCML CFU-M progenitors suppress erythroid growth. Furthcr- interpreted to indicate hypersensitivity to Epo. Although maturation levels varied from patient to patient the cndogenous crythroid colonies were usually poorly hemoglobinizcd, as is the cxpericnce with thc other discasc statcs (cg, PV, CML). It is also possiblc that thcir numbers arc underestimated because of our inability to detect thcm (ic, lack of hcmoglobinization).
Thc globin synthctic profile of BFUe-derived JCML colonies was thc main focus of our study. The majority of the cases studied showed over 80% Hb F by globin biosynthesis. Such high lcvcls of y globin have not hecn obscrvcd beforc in cultures of adult individuals and, in fact, arc even highcr than those usually mcasurcd in newborn progenitors.'' It is of interest that in almost all of the cascs wc studied the proportion of Gy chains was ovcr 50%. Thus, these globin synthctic profiles arc reminiscent of the ones scen in late gestation fetal livers, or in prcmaturc nconatcs.
In addition to fctal globin, noted in isolated reports before,\h" we detectcd thc expression of the cmbryonic globins, e and 5, at the protein and mRNA level.' This finding has not been previously rcportcd for primary lcukcmic cells. However, cmbryonic globins arc abundantly produced in erythrolcukcmic lines cstablishcd from thc cclls of patients with Icukcmias."l'"' A s shown in Fig 5, e RNA was present both in primary nonculturcd lcukcmic By sevcral criteria the abundant erythroid colony growth obscrved in our cascs is belicved to bc derived from leukemic rathcr than from normal erythroid progenitors: (1) thcir morphology (tight, single rather than multiclustered colonies) and thcir poor tcndency to hcmoglobinizc were distinct from normal; (2) the lcvcl of fctal globin was extremcly high, which rcflectcd the high levcls of Hb F found in thc PB of thcsc paticnts; (3) a significant number of "cndogcnous" colonies can be prcscnt in many of thcsc paticnts; and (4) as is the casc with fctal cells;w FSS or FCS-T failcd to influencc the lcvcls of Hb F synthcsizcd by these colonies. Normal progenitor growth, if present in thcsc cases, rcmaincd undctcctcd.
One of thc intcrcsting qucstions is why high Hb F is found with some consistency in JCML. Initially it was suggcsted that this phcnomcnon reflected the transformation of a rare ccll found postnatally that has cscapcd the full dcvclopmcntal switch (from y to p) during thc perinatal period and that is rcsponsiblc for the production of Hb Fcontaining cclls (F cclls) in adult lift.'.",' Howcvcr, sevcral picccs of cvidcncc gathcrcd subsequently" suggested that the fetal to adult dcvclopmcntal changes in crythroid cells arc mcdiatcd not through changes in ccll lincagcs but in programs within a singlc lincagc, and that Hb F production is an inhcrcnt, facultativc propcrty of adult stcm cclls. Also, transformation of incompletely "switchcd" cclls in utcro docs not appcar likcly bccausc c a m diagnoscd soon after birth as opposed to the caws diagnoscd a fcw ycars later do not appcar to havc highcr lcvcls of Hb F (Tablc 1). intriguing entity may provide insights about the biologic bchavior of JCML erythroid cclls.
